![[(2R,3S,4R,5R)-5-(6-azanyl-8-oxo-7H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate in PDB entry 3mwk, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/3mwk_entity_3_side_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>3mwk</span> contains 1 copy of <span class='highlight'>[(2R,3S,4R,5R)-5-(6-azanyl-8-oxo-7H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate</span>. Side view.")
![[(2R,3S,4R,5R)-5-(6-azanyl-8-oxo-7H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate in PDB entry 3mwk, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/3mwk_entity_3_top_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>3mwk</span> contains 1 copy of <span class='highlight'>[(2R,3S,4R,5R)-5-(6-azanyl-8-oxo-7H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate</span>. Top view.")
Environment details NEW
8OP 209 bound to chain B
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.